HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lee M Greenberger Selected Research

Irinotecan (Camptosar)

9/2011Potent and sustained inhibition of HIF-1α and downstream genes by a polyethyleneglycol-SN38 conjugate, EZN-2208, results in anti-angiogenic effects.
10/2010Tumor regression and curability of preclinical neuroblastoma models by PEGylated SN38 (EZN-2208), a novel topoisomerase I inhibitor.
4/2008Novel prodrugs of SN38 using multiarm poly(ethylene glycol) linkers.
3/2008Novel delivery of SN38 markedly inhibits tumor growth in xenografts, including a camptothecin-11-refractory model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lee M Greenberger Research Topics

Disease

25Neoplasms (Cancer)
11/2022 - 04/2003
5Carcinoma (Carcinomatosis)
03/2008 - 04/2003
4COVID-19
01/2024 - 11/2021
3Leukemia
01/2024 - 05/2023
3Lymphoma (Lymphomas)
01/2024 - 05/2023
3Hematologic Neoplasms (Hematological Malignancy)
10/2023 - 01/2021
3Hypoxia (Hypoxemia)
09/2011 - 11/2008
2Multiple Myeloma
01/2024 - 05/2023
2Prostatic Neoplasms (Prostate Cancer)
12/2011 - 08/2004
2Neoplasm Metastasis (Metastasis)
01/2009 - 11/2008
2Breast Neoplasms (Breast Cancer)
10/2004 - 01/2004
1Graft vs Host Disease (Graft-Versus-Host Disease)
05/2023
1Infections
11/2022
1Glioma (Gliomas)
09/2011
1Neuroblastoma
10/2010
1Necrosis
10/2010
1Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2009
1Corneal Neovascularization
01/2009
1Glioblastoma (Glioblastoma Multiforme)
11/2008
1Colorectal Neoplasms (Colorectal Cancer)
04/2008
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2004

Drug/Important Bio-Agent (IBA)

6Member 1 Subfamily B ATP Binding Cassette TransporterIBA
02/2006 - 04/2003
5Proteins (Proteins, Gene)FDA Link
12/2011 - 08/2004
5Paclitaxel (Taxol)FDA LinkGeneric
06/2006 - 04/2003
4Irinotecan (Camptosar)FDA LinkGeneric
09/2011 - 03/2008
4EZN-2208IBA
09/2011 - 03/2008
4HTI-286IBA
05/2005 - 04/2003
3COVID-19 VaccinesIBA
11/2022 - 01/2021
3Messenger RNA (mRNA)IBA
12/2011 - 11/2008
3LuciferasesIBA
12/2011 - 10/2010
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2011 - 01/2009
2Immunoglobulin G (IgG)IBA
01/2024 - 05/2023
2Phosphotransferases (Kinase)IBA
04/2013 - 02/2008
2Antisense OligonucleotidesIBA
12/2011 - 02/2010
2AndrogensIBA
12/2011 - 08/2004
2Transcription Factors (Transcription Factor)IBA
12/2011 - 11/2008
2Topoisomerase I InhibitorsIBA
09/2011 - 10/2010
2Cisplatin (Platino)FDA LinkGeneric
10/2010 - 03/2005
2Vincristine (Oncovin)FDA LinkGeneric
10/2010 - 04/2003
2ProdrugsIBA
10/2010 - 04/2008
2Docetaxel (Taxotere)FDA Link
06/2006 - 09/2003
2hemiasterlinIBA
05/2005 - 11/2004
1cilgavimabIBA
10/2023
1tixagevimabIBA
10/2023
1VaccinesIBA
05/2023
1mRNA VaccinesIBA
11/2022
1Lapatinib (GW572016)FDA Link
04/2013
1Tyrosine Kinase InhibitorsIBA
04/2013
1Neutralizing AntibodiesIBA
04/2013
1Gefitinib (Iressa)FDA Link
04/2013
1Androgen Receptors (Androgen Receptor)IBA
12/2011
15'-ACCaagtttcttcAGC-3'IBA
12/2011
1LigandsIBA
12/2011
1abirateroneIBA
12/2011
1enzalutamideIBA
12/2011
1Testosterone (Sustanon)FDA Link
12/2011
1matrigelIBA
09/2011
1AntibodiesIBA
10/2010
1DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
10/2010
1Doxorubicin (Adriamycin)FDA LinkGeneric
10/2010
1Histones (Histone)IBA
10/2010
1FenretinideIBA
10/2010
1Topotecan (Hycamtin)FDA LinkGeneric
10/2010
1Matrix Metalloproteinases (MMPs)IBA
10/2010
1Therapeutic UsesIBA
10/2010
1locked nucleic acidIBA
02/2010
1SurvivinIBA
02/2010
1EZN 3042IBA
02/2010
1Polyethylene (Polythene)IBA
10/2009
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2009
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
01/2009
11- (4- (6- amino- 5- (methoxyiminomethyl)pyrimidin- 4- yloxy)- 2- chlorophenyl)- 3- ethylureaIBA
01/2009
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2008
1RNA (Ribonucleic Acid)IBA
11/2008
1Glucose (Dextrose)FDA LinkGeneric
11/2008
1EZN 2968IBA
11/2008
1Antineoplastic Agents (Antineoplastics)IBA
03/2008
1JNJ 28871063IBA
02/2008
1Tyrosine (L-Tyrosine)FDA Link
02/2008
1pyrazoleIBA
08/2007
1benzocycloheptapyridineIBA
08/2007
1JNJ-7706621IBA
10/2006
1Cyclin-Dependent Kinases (cdk Proteins)IBA
10/2006
1Aurora KinasesIBA
10/2006
1taxaneIBA
06/2006
1MST 997IBA
06/2006
1CL 347099IBA
02/2006
1AntigensIBA
03/2005
1CalicheamicinsIBA
03/2005
1Anti-Bacterial Agents (Antibiotics)IBA
03/2005
1CarbohydratesIBA
03/2005
1AmidesIBA
03/2005
1TubulinIBA
11/2004
1multidrug resistance-associated protein 1IBA
10/2004
1HTI 042IBA
09/2004

Therapy/Procedure

7Therapeutics
01/2024 - 08/2004
2Transplantation
01/2024 - 05/2023
1Castration
12/2011
1Aftercare (After-Treatment)
09/2011
1Injections
03/2008